Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB06071> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB06071 type drugbank_vocabulary:Drug assertion.
- drugbank:DB06071 label "DTS-201 [drugbank:DB06071]" assertion.
- drugbank:DB06071 seeAlso DB06071 assertion.
- drugbank:DB06071 description "DTS-201 is a prodrug of doxorubicin, a widely used anti-cancer drug that Diatos intends to develop for the treatment of various solid tumors. It is activated in the tumor environment. DTS-201 may be suitable for the treatment of many types of solid tumors, including tumors sensitive to doxorubicin and potentially other tumors which are not currently treated with doxorubicin but which express high levels of CD-10* or TOP** peptidases, such as prostate cancer, colorectal cancer, melanoma, pancreatic cancer and some types of renal cancer." assertion.
- drugbank:DB06071 identifier "drugbank:DB06071" assertion.
- drugbank:DB06071 title "DTS-201" assertion.
- drugbank:DB06071 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB06071 drugbank_vocabulary:drugbank-id "DB06071" assertion.
- drugbank:DB06071 bio2rdf_vocabulary:x-identifiers.org DB06071 assertion.
- drugbank:DB06071 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB06071" assertion.
- drugbank:DB06071 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB06071 bio2rdf_vocabulary:identifier "DB06071" assertion.